CN Stock MarketDetailed Quotes
600055 Beijing Wandong Medical Technology
- 16.79
- -0.60-3.45%
Market Closed Dec 13 15:00 CST
11.80BMarket Cap64.08P/E (TTM)
17.60High16.78Low112.90KlotVolume17.38Open17.39Pre Close193.42MTurnover2.09%Turnover Ratio62.65P/E (Static)703.06MShares18.4652wk High6.03P/B9.08BFloat Cap11.1052wk Low19.13Limit Up540.82MShs Float37.62Historical High15.65Limit Down4.72%Amplitude0.21Historical Low0.13Dividend TTM17.13Avg Price68.15KlotAsk0.77%Div YieldTTM100Lot Size41.61KlotBid
Beijing Wandong Medical Technology Key Stats
All
YOY
| (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | 18.07%1.09B | 17.79%700.09M | 20.94%308.5M | 10.30%1.24B | 26.36%925.79M | 30.19%594.33M | 21.12%255.08M | -3.02%1.12B | -8.50%732.66M | -7.74%456.52M |
| Operating revenue | 18.07%1.09B | 17.79%700.09M | 20.94%308.5M | 10.30%1.24B | 26.36%925.79M | 30.19%594.33M | 21.12%255.08M | -3.02%1.12B | -8.50%732.66M | -7.74%456.52M |
| Other operating revenue | ---- | 16.04%28.36M | ---- | 39.65%75.73M | ---- | 2.34%24.44M | ---- | 0.14%54.23M | ---- | 11.95%23.88M |
| Total operating cost | 17.85%973.08M | 15.64%611.62M | 19.44%277.82M | 16.23%1.11B | 32.14%825.71M | 32.67%528.91M | 22.00%232.59M | -3.55%951.61M | -8.81%624.9M | -5.72%398.68M |
| Operating cost | 24.65%674.08M | 20.17%423.3M | 26.08%192.94M | 13.72%712.58M | 32.60%540.76M | 38.32%352.26M | 38.87%153.03M | 0.03%626.61M | -2.12%407.82M | -0.38%254.67M |
| Operating tax surcharges | 14.62%8.43M | 5.81%6.21M | -50.66%761.83K | -21.07%11.86M | -7.77%7.35M | -0.67%5.87M | 1.73%1.54M | 0.46%15.02M | -6.81%7.97M | -6.37%5.91M |
| Operating expense | -0.23%163.37M | -5.83%99.98M | 3.98%49.63M | 27.98%223.26M | 38.96%163.75M | 34.52%106.16M | 21.33%47.73M | -5.93%174.46M | -17.14%117.83M | -10.69%78.92M |
| Administration expense | -1.88%57.19M | -5.99%38.12M | -3.67%17.95M | 19.32%80.77M | 14.37%58.29M | 17.01%40.55M | -1.51%18.63M | -4.05%67.69M | -0.10%50.96M | -7.76%34.65M |
| Financial expense | 16.05%-45.51M | 13.66%-34.97M | -8.52%-18.66M | -14.42%-80.01M | -24.32%-54.21M | -63.20%-40.5M | -311.88%-17.19M | -214.34%-69.92M | -653.32%-43.61M | -682.87%-24.82M |
| -Interest expense (Financial expense) | -28.27%408.04K | -28.27%282.24K | ---- | -14.40%1.25M | -1.15%568.85K | 13.30%393.47K | --98.14K | -2.61%1.47M | --575.49K | --347.27K |
| -Interest Income (Financial expense) | 4.01%-48.87M | 5.31%-34.31M | -0.16%-18.72M | -31.42%-81.13M | -54.45%-50.91M | -87.87%-36.23M | -304.51%-18.69M | -136.48%-61.73M | -409.60%-32.96M | -384.52%-19.28M |
| Research and development | 5.23%115.52M | 22.33%78.99M | 21.98%35.19M | 14.38%157.56M | 30.82%109.77M | 30.86%64.57M | 16.04%28.85M | 23.57%137.76M | 15.47%83.91M | 29.26%49.34M |
| Credit Impairment Loss | -18.27%2.38M | -18.27%2.38M | ---- | 67.58%-7.45M | 143.95%2.91M | 143.95%2.91M | 5,571.88%85.24K | -33.42%-22.99M | -50.79%-6.62M | -51.18%-6.62M |
| Asset Impairment Loss | -421.39%-4.87K | -421.39%-4.87K | ---- | 55.09%-2.11M | 48.53%1.52K | 48.53%1.52K | ---- | 31.62%-4.7M | -99.86%1.02K | -99.60%1.02K |
| Other net revenue | -58.46%19.19M | -53.06%13.42M | -46.93%6.88M | 260.20%82.68M | 84.90%46.2M | 117.59%28.58M | 23.04%12.97M | -41.38%22.95M | -31.06%24.99M | -54.57%13.14M |
| Fair value change income | 2,114.76%1.19M | 1,358.72%781.48K | ---- | 1,096.13%34.59M | 100.88%53.57K | 101.02%53.57K | 101.17%53.57K | -61.98%-3.47M | -1,677.57%-6.11M | -1,421.32%-5.23M |
| Invest income | -44.37%2.92M | -12.48%1.48M | -77.01%131.43K | -61.25%8.29M | -63.30%5.24M | -82.14%1.69M | -92.13%571.64K | 1.93%21.39M | 12.92%14.29M | -18.15%9.48M |
| -Including: Investment income associates | 116.03%148.28K | 76.57%-111.34K | 111.03%28.28K | -951.31%-2.05M | -518.24%-925.01K | -400.49%-475.13K | -535.08%-256.5K | -149.64%-195.21K | -66.50%221.17K | -70.67%158.12K |
| Asset deal income | 2,268.30%26.63K | -57.79%24.51K | ---- | 83.13%-301.52K | 100.47%1.12K | 126.55%58.07K | 113.74%38.52K | -648.78%-1.79M | -53.80%-241.15K | -50.67%-218.72K |
| Other revenue | -66.60%12.69M | -63.32%8.75M | -44.75%6.75M | 43.92%49.66M | 60.52%37.99M | 51.84%23.87M | 50.59%12.22M | -22.72%34.51M | -14.65%23.67M | -28.35%15.72M |
| Operating profit | -4.84%139.2M | 8.38%101.88M | 5.93%37.56M | 10.79%213.33M | 10.20%146.28M | 32.44%94M | 16.32%35.46M | -7.76%192.55M | -12.47%132.74M | -29.63%70.98M |
| Add:Non operating Income | 9,131.33%1.05M | 13,413.89%1.46M | ---- | 4,150.52%866.89K | 18,925.67%11.42K | 17,925.67%10.82K | --3.46K | 883.19%20.39K | -97.11%60 | -97.11%60 |
| Less:Non operating expense | 112.24%1.11M | 3,067.60%941.89K | 85.22%21.41K | 564.09%860.99K | --523.48K | --29.74K | --11.56K | -91.47%129.65K | ---- | ---- |
| Total profit | -4.55%139.14M | 8.95%102.4M | 5.89%37.54M | 10.86%213.33M | 9.81%145.77M | 32.41%93.99M | 16.30%35.45M | -7.14%192.44M | -12.35%132.74M | -29.49%70.98M |
| Less:Income tax cost | -5.97%22.51M | 3.43%16.9M | -41.74%3.37M | 10.41%22.52M | -18.70%23.94M | 43.10%16.34M | 13.28%5.78M | -24.33%20.4M | -7.64%29.45M | -36.84%11.42M |
| Net profit | -4.27%116.63M | 10.12%85.5M | 15.16%34.17M | 10.91%190.81M | 17.94%121.82M | 30.36%77.64M | 16.90%29.67M | -4.56%172.04M | -13.61%103.29M | -27.88%59.56M |
| Net profit from continuing operation | -4.27%116.63M | 10.12%85.5M | 15.16%34.17M | 10.91%190.81M | 17.94%121.82M | 30.36%77.64M | 16.90%29.67M | -4.56%172.04M | -13.61%103.29M | -27.88%59.56M |
| Less:Minority Profit | -45.55%892.92K | -52.78%756.27K | 219.72%915.58K | 168.18%2.27M | 873.45%1.64M | 545.42%1.6M | -201.96%-764.8K | -13.73%-3.33M | 122.55%168.46K | 139.42%248.14K |
| Net profit of parent company owners | -3.70%115.73M | 11.44%84.74M | 9.26%33.26M | 7.51%188.54M | 16.54%120.18M | 28.21%76.04M | 23.57%30.44M | -4.27%175.37M | -14.29%103.13M | -28.72%59.31M |
| Earning per share | ||||||||||
| Basic earning per share | -3.51%0.165 | 9.09%0.12 | 9.30%0.047 | 0.00%0.27 | 6.88%0.171 | 10.00%0.11 | -6.52%0.043 | -20.59%0.27 | -28.25%0.16 | -33.33%0.1 |
| Diluted earning per share | -3.51%0.165 | 9.09%0.12 | 9.30%0.047 | 0.00%0.27 | 6.88%0.171 | 10.00%0.11 | -6.52%0.043 | -20.59%0.27 | -28.25%0.16 | -33.33%0.1 |
| Other composite income | -100.25%-1.35M | -48.41%-674.9K | ||||||||
| Other composite income of parent company owners | ---- | ---- | ---- | -100.25%-1.35M | ---- | ---- | ---- | -48.41%-674.9K | ---- | ---- |
| Total composite income | -4.27%116.63M | 10.12%85.5M | 15.16%34.17M | 10.56%189.46M | 17.94%121.82M | 30.36%77.64M | 16.90%29.67M | -4.70%171.36M | -13.61%103.29M | -27.88%59.56M |
| Total composite income of parent company owners | -3.70%115.73M | 11.44%84.74M | 9.26%33.26M | 7.15%187.19M | 16.54%120.18M | 28.21%76.04M | 23.57%30.44M | -4.40%174.69M | -14.29%103.13M | -28.72%59.31M |
| Total composite income of minority owners | -45.55%892.92K | -52.78%756.27K | 219.72%915.58K | 168.18%2.27M | 873.45%1.64M | 545.42%1.6M | -201.96%-764.8K | -13.73%-3.33M | 122.55%168.46K | 139.42%248.14K |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- |
| Auditor | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- | -- | Lixin Certified Public Accountants (Special General Partnership) | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CN
Overall
Symbol
Price
% Chg
No Data
